Shapiro, A <br/><br/>
Low risk of viral infection after administration of vapor-heated factor VII concentrate or factor IX complex in first-time recipients of blood components. International Factor Safety Study Group.  [electronic resource] 

 -  Transfusion  Mar 1995 
 - 204-8 p.  digital 
<br/><br/> Publication Type: Clinical Trial; Controlled Clinical Trial; Journal Article 
<br/><br/><label>ISSN: </label>0041-1132 
<br/><br/><label>Standard No.: </label>10.1046/j.1537-2995.1995.35395184275.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Adult<br/>Aged<br/>Aged, 80 and over<br/>Factor IX--therapeutic use<br/>Factor VII--therapeutic use<br/>Female<br/>HIV Infections--prevention & control<br/>Hemophilia B--drug therapy<br/>Hepatitis B--prevention & control<br/>Hepatitis C--prevention & control<br/>Hot Temperature<br/>Humans<br/>Infant<br/>Infant, Newborn<br/>Male<br/>Plasma--virology<br/>Risk Factors<br/>Virus Diseases--prevention & control<br/>Volatilization